Discovery and Preclinical Development of IIIM-290, an Orally Active Potent Cyclin-Dependent Kinase Inhibitor.
暂无分享,去创建一个
S. Bhushan | D. Mondhe | S. Bharate | Sonali S. Bharate | R. Vishwakarma | S. Guru | Vikas Kumar | Sumit G. Gandhi | Shreyans K. Jain | M. Mintoo | M. Sharma | V. Nuthakki